Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy
Yıl: 2022 Cilt: 52 Sayı: 2 Sayfa Aralığı: 522 - 523 Metin Dili: İngilizce DOI: 10.55730/1300-0144.5341 İndeks Tarihi: 15-06-2022
Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Baddley JW, Cantini F, Goletti D, Gómez-Reino JJ, Mylonakis E et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules: anti-tumor necrosis factor-α agents). Clinical Microbiology and Infection. 2018; 24: 10–20. doi:10.1016/j.cmi.2017.12.025
- 2. Ouédraogo D-D, Tiendrébéogo WJS, Kaboré F, Ntsiba H. COVID-19, chronic inflammatory rheumatic disease and antirheumatic treatments. Clinical Rheumatology. 2020; 39: 2069– 2075
- 3. Haberman R, Axelrad J, Chen A, Castillo R, Yan D et al. Covid-19 in Immune-Mediated Inflammatory Diseases-Case Series from New York. New England Journal of Medicine. 2020; 383(1): 85-88. doi: 10.1056/NEJMc2009567
- 4. Esatoglu SN, Tascilar K, Babaoğlu H, Bes C, Yurttas B et al. COVID-19 Among Patients With Inflammatory Rheumatic Diseases. Frontiers in Immunology. 2021; 12: 651715. doi: 10.3389/fimmu.2021.651715
- 5. Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D et al. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med (New York). 2020; 1: 90– 102. doi: 10.1016/j.medj.2020.11.005
| APA | türk s, emeksiz z, Karatas D, Erkorkmaz Ü, Gönüllü E (2022). Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. , 522 - 523. 10.55730/1300-0144.5341 |
| Chicago | türk sümeyye merve,emeksiz zeynep,Karatas Damla,Erkorkmaz Ünal,Gönüllü Emel Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. (2022): 522 - 523. 10.55730/1300-0144.5341 |
| MLA | türk sümeyye merve,emeksiz zeynep,Karatas Damla,Erkorkmaz Ünal,Gönüllü Emel Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. , 2022, ss.522 - 523. 10.55730/1300-0144.5341 |
| AMA | türk s,emeksiz z,Karatas D,Erkorkmaz Ü,Gönüllü E Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. . 2022; 522 - 523. 10.55730/1300-0144.5341 |
| Vancouver | türk s,emeksiz z,Karatas D,Erkorkmaz Ü,Gönüllü E Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. . 2022; 522 - 523. 10.55730/1300-0144.5341 |
| IEEE | türk s,emeksiz z,Karatas D,Erkorkmaz Ü,Gönüllü E "Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy." , ss.522 - 523, 2022. 10.55730/1300-0144.5341 |
| ISNAD | türk, sümeyye merve vd. "Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy". (2022), 522-523. https://doi.org/10.55730/1300-0144.5341 |
| APA | türk s, emeksiz z, Karatas D, Erkorkmaz Ü, Gönüllü E (2022). Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. Turkish Journal of Medical Sciences, 52(2), 522 - 523. 10.55730/1300-0144.5341 |
| Chicago | türk sümeyye merve,emeksiz zeynep,Karatas Damla,Erkorkmaz Ünal,Gönüllü Emel Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. Turkish Journal of Medical Sciences 52, no.2 (2022): 522 - 523. 10.55730/1300-0144.5341 |
| MLA | türk sümeyye merve,emeksiz zeynep,Karatas Damla,Erkorkmaz Ünal,Gönüllü Emel Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. Turkish Journal of Medical Sciences, vol.52, no.2, 2022, ss.522 - 523. 10.55730/1300-0144.5341 |
| AMA | türk s,emeksiz z,Karatas D,Erkorkmaz Ü,Gönüllü E Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. Turkish Journal of Medical Sciences. 2022; 52(2): 522 - 523. 10.55730/1300-0144.5341 |
| Vancouver | türk s,emeksiz z,Karatas D,Erkorkmaz Ü,Gönüllü E Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy. Turkish Journal of Medical Sciences. 2022; 52(2): 522 - 523. 10.55730/1300-0144.5341 |
| IEEE | türk s,emeksiz z,Karatas D,Erkorkmaz Ü,Gönüllü E "Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy." Turkish Journal of Medical Sciences, 52, ss.522 - 523, 2022. 10.55730/1300-0144.5341 |
| ISNAD | türk, sümeyye merve vd. "Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy". Turkish Journal of Medical Sciences 52/2 (2022), 522-523. https://doi.org/10.55730/1300-0144.5341 |
